about
Improving Obesity Prevention and Management in Primary Care in Canada.Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family PracticeImplementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial.Implementing and evaluating a program to facilitate chronic disease prevention and screening in primary care: a mixed methods program evaluationImproving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial.The 5As team intervention: bridging the knowledge gap in obesity management among primary care practitionersDeveloping clinical decision tools to implement chronic disease prevention and screening in primary care: the BETTER 2 program (building on existing tools to improve chronic disease prevention and screening in primary care).The 5As team patient study: patient perspectives on the role of primary care in obesity management.Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis.5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools.How to use an article about a diagnostic test.Missing an opportunity: the embedded nature of weight management in primary careChallenges in interdisciplinary weight management in primary care: lessons learned from the 5As Team study.Impact of the 5As Team study on clinical practice in primary care obesity management: a qualitative study.Reflections on using non-inferiority randomised placebo controlled trials in assessing cardiovascular safety of new agents for treatment of type 2 diabetes.Televised medical talk shows--what they recommend and the evidence to support their recommendations: a prospective observational study.Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein.Improving reporting and utility of evaluations of complex interventions.Exenatide may improve maintenance of HbA1c targets, with less hypoglycaemia, but more early adverse effects when compared with low-dose glimepirideW13– Primary prevention in primary careThe 11th hour--time for EBM to return to first principles?Redefining obesity: Beyond the numbersImproving obesity management training in family medicine: multi-methods evaluation of the 5AsT-MD pilot courseEvidence from large Danish cohort does not support an association between the MMR vaccine and autism: facts in a post-truth world
P50
Q30249354-5C10A28C-57FF-4B31-9CAC-AF413303AC0CQ33552735-112CF1B7-0655-4F4D-81B5-57DDD5DC0D03Q33826442-D59C04B0-3E04-4984-9AB7-CC0818EB71EAQ34325970-774A45EE-909B-4B54-9AEB-E806364A89FCQ34477982-D4A6AC62-277C-4D16-9B6D-39094A6AFF96Q35875864-0413B024-3770-4C00-A697-B1C8AE4E2269Q35913484-1135D7ED-3315-4A05-B214-F6EFE161FCBDQ36274507-9948D086-0EEE-4D4D-80C8-975C1BF1C2CFQ36278380-7C0D3388-D011-465E-8E34-DB478D49B950Q36584445-6C016EC6-3F37-4877-890C-67681A293ACAQ37190047-1BA54182-5542-497F-8106-515349A3B5EDQ37308812-B4B07184-8B1F-48CB-BB77-6EFBF6AE83F1Q37418083-3FF3B7E9-DAC6-44F2-8F8A-85A9ACC30C34Q38815959-5048C3F3-371F-447F-9FA8-3D5E066B4983Q39169329-F7BBD6DB-656E-458A-98AF-BF9791820618Q43069687-B8D0BB3D-31EA-4200-A194-8CEE4F484185Q46068618-3BBDEF7B-617B-4706-AD0F-F7792091E524Q50272788-EE5964EE-55C2-4DB0-80C8-20F3A9A4ABE6Q58393403-9D75B8B4-31BE-4E7B-BCDA-32447E4DEC16Q58834323-A5AEE012-9D9B-4530-B6D1-472EA58AE790Q84466574-11A41805-6FB0-4ED6-B938-A0F73D88678BQ87685664-DE4352D1-D39F-4000-A474-A568CA0596C8Q92475971-67F804F5-4E1B-41AA-93E9-B0B26019E689Q92883380-B1D6E59C-C65B-480C-B381-B9765CBF7CD1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Denise L Campbell-Scherer
@ast
Denise L Campbell-Scherer
@en
Denise L Campbell-Scherer
@es
Denise L Campbell-Scherer
@nl
Denise L Campbell-Scherer
@sl
type
label
Denise L Campbell-Scherer
@ast
Denise L Campbell-Scherer
@en
Denise L Campbell-Scherer
@es
Denise L Campbell-Scherer
@nl
Denise L Campbell-Scherer
@sl
prefLabel
Denise L Campbell-Scherer
@ast
Denise L Campbell-Scherer
@en
Denise L Campbell-Scherer
@es
Denise L Campbell-Scherer
@nl
Denise L Campbell-Scherer
@sl
P106
P31
P496
0000-0002-2500-8207